Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment
Clinical trial NCT02696642 · COMPLETED
Trial details
- NCT number
- NCT02696642
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2018-07-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.